Literature DB >> 24845128

Polysaccharide-based micro/nanohydrogels for delivering macromolecular therapeutics.

Kuntal Ganguly1, Kiran Chaturvedi1, Uttam A More1, Mallikarjuna N Nadagouda1, Tejraj M Aminabhavi2.   

Abstract

Increased interest in developing novel micro/nanohydrogel based formulations for delivering macromolecular therapeutics has led to multiple choices of biodegradable and biocompatible natural polymers. This interest is largely due to the availability of large number of highly pure recombinant proteins and peptides with tunable properties as well as RNA interference technology that are used in treating some of the deadly diseases that were difficult to be treated by the conventional approaches. The majority of marketed drugs that are now available are in the form of injectables that pose limited patient compliance and convenience. On the other hand, micro/nanotechnology based macromolecular delivery formulations offer many alternative routes of administration and advantages with improved patient compliance and efficient or targeted delivery of intracellular therapeutics to the site of action. This review outlines and critically evaluates the research findings on micro and nano-carrier polymeric hydrogels for the delivery of macromolecular therapeutics.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Genes; Hormones; Macromolecules; Microspheres; Nanohydrogels; Peptides/proteins

Mesh:

Substances:

Year:  2014        PMID: 24845128     DOI: 10.1016/j.jconrel.2014.05.014

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  21 in total

Review 1.  Designing polymers with sugar-based advantages for bioactive delivery applications.

Authors:  Yingyue Zhang; Jennifer W Chan; Alysha Moretti; Kathryn E Uhrich
Journal:  J Control Release       Date:  2015-09-28       Impact factor: 9.776

2.  Nanogels of methylcellulose hydrophobized with N-tert-butylacrylamide for ocular drug delivery.

Authors:  Marion Jamard; Todd Hoare; Heather Sheardown
Journal:  Drug Deliv Transl Res       Date:  2016-12       Impact factor: 4.617

3.  Development of acid-resistant alginate/trimethyl chitosan nanoparticles containing cationic β-cyclodextrin polymers for insulin oral delivery.

Authors:  Maryam Mansourpour; Reza Mahjub; Mohsen Amini; Seyed Naser Ostad; Elnaz Sadat Shamsa; Morteza Rafiee-Tehrani; Farid Abedin Dorkoosh
Journal:  AAPS PharmSciTech       Date:  2015-01-22       Impact factor: 3.246

4.  Synergistic Combination of Sodium Aescinate-Stabilized, Polymer-Free, Twin-Like Nanoparticles to Reverse Paclitaxel Resistance.

Authors:  Juan Li; Lei Zheng; Rongmei Wang; Deqing Sun; Shuang Liang; Jing Wu; Yongqing Liu; Xiaona Tian; Tingting Li; Yang Yang; Leiqiang Han
Journal:  Int J Nanomedicine       Date:  2020-08-06

Review 5.  Polydopamine, harness of the antibacterial potentials-A review.

Authors:  Xiaojun He; Enoch Obeng; Xiaoshuai Sun; Nahyun Kwon; Jianliang Shen; Juyoung Yoon
Journal:  Mater Today Bio       Date:  2022-06-16

Review 6.  Nanogels: An overview of properties, biomedical applications and obstacles to clinical translation.

Authors:  Kruti S Soni; Swapnil S Desale; Tatiana K Bronich
Journal:  J Control Release       Date:  2015-11-10       Impact factor: 9.776

Review 7.  Polysaccharide-based nanoparticles for theranostic nanomedicine.

Authors:  M Swierczewska; H S Han; K Kim; J H Park; S Lee
Journal:  Adv Drug Deliv Rev       Date:  2015-11-27       Impact factor: 15.470

8.  Analyzing collaboration networks and developmental patterns of nano-enabled drug delivery (NEDD) for brain cancer.

Authors:  Ying Huang; Jing Ma; Alan L Porter; Seokbeom Kwon; Donghua Zhu
Journal:  Beilstein J Nanotechnol       Date:  2015-07-31       Impact factor: 3.649

Review 9.  Present and future medical applications of microbial exopolysaccharides.

Authors:  Misu Moscovici
Journal:  Front Microbiol       Date:  2015-09-29       Impact factor: 5.640

10.  CD147 monoclonal antibody mediated by chitosan nanoparticles loaded with α-hederin enhances antineoplastic activity and cellular uptake in liver cancer cells.

Authors:  Rong Zhu; Chun-ge Zhang; Yang Liu; Zhi-qiang Yuan; Wei-liang Chen; Shu-di Yang; Ji-zhao Li; Wen-jing Zhu; Xiao-feng Zhou; Ben-gang You; Xue-nong Zhang
Journal:  Sci Rep       Date:  2015-12-07       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.